High-dose continuous renal replacement therapy for neonatal hyperammonemia

Pediatric Nephrology

Volumn 28, Issue 6, 2013, Pages 983-986

  Spinale, Joann M ^a   Laskin, Benjamin L ^a   Sondheimer, Neal ^a   Swartz, Sarah J ^b   Goldstein, Stuart L ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ARGININE; BENZOIC ACID; BICARBONATE; CREATININE; DOPAMINE; INSULIN; MESOGLYCAN; PHENYLACETIC ACID; POTASSIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE;

AMMONIA BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BRAIN HEMORRHAGE; CASE REPORT; COMPARTMENT SYNDROME; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSIS CATHETER; EMERGENCY WARD; ERYTHROCYTE; FASCIOTOMY; FEMORAL ARTERY; FLOW RATE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; HYPERAMMONEMIA; LIVER TRANSPLANTATION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; PRESCRIPTION; PRIORITY JOURNAL;

HUMANS; HYPERAMMONEMIA; INFANT, NEWBORN; MALE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY;

EID: 84880572711     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2441-8     Document Type: Article

References (15)

1. Mathias RS, Kostiner D, Packman S (2001) Hyperammonemia in urea cycle disorders: role of the nephrologist. Am J Kidney Dis 37:1069-1080
2. Picca S, Bartuli A, Dionisi-Vici C (2008) Medical management and dialysis therapy for the infant with an inborn error of metabolism. Semin Nephrol 28:477-480
3. Pela I, Seracini D, Donati MA, Lavoratti G, Pasquini E, Materassi M (2008) Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date? Pediatr Nephrol 23:163-168
4. Bunchman TE, Barletta GM, Winters JW, Gardner JJ, Crumb TL, McBryde KD (2007) Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration. Pediatr Nephrol 22:1062-1065
5. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500-1505
6. Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356:2282-2292
7. Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 14:910-918
8. Fakler CR, Kaftan HA, Nelin LD (1995) Two cases suggesting a role for the L-arginine nitric oxide pathway in neonatal blood pressure regulation. Acta Paediatr 84:460-462
9. Bunchman TE, Brophy PD, Goldstein SL (2008) Technical considerations for renal replacement therapy in children. Semin Nephrol 28:488-492
10. Phan V, Clermont MJ, Merouani A, Litalien C, Tucci M, Lambert M, Mitchell G, Jouvet P (2006) Duration of extracorporeal therapy in acute maple syrup urine disease: a kinetic model. Pediatr Nephrol 21:698-704
11. McBryde KD, Kershaw DB, Bunchman TE, Maxvold NJ, Mottes TA, Kudelka TL, Brophy PD (2006) Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 148:770-778
12. Hackbarth R, Bunchman TE, Chua AN, Somers MJ, Baum M, Symons JM, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Alexander SR, Mahan JD, McBryde KD, Benfield MR, Goldstein SL (2007) The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs 30:1116-1121
13. Puliyanda DP, Harmon WE, Peterschmitt MJ, Irons M, Somers MJ (2002) Utility of hemodialysis in maple syrup urine disease. Pediatr Nephrol 17:239-242
14. Wong KY, Wong SN, Lam SY, Tam S, Tsoi NS (1998) Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 12:589-591
15. Chen CY, Tsai TC, Lee WJ, Chen HC (2007) Aminograms during continuous hemodiafiltration in the treatment of hyperammonemia due to ornithine transcarbamylase deficiency. Ren Fail 29:661-665